In the present study, SACC patients have higher plasma IFN-γ levels than those with OSCC, an immunologically hot tumor enrolled here as control, which is consistent with a previous study.17 In contrast to OSCC, SACC expressed lower level of cellular PD-L1. The gene discussed is CD274; the disease is neoplasm.